- 米国企業
- Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc.DRMA
| 2021年 12月31日 | 2022年 12月31日 |
---|
Cash and cash equivalents | 11 | 6 |
---|
Prepaid expenses and other current assets | 825,134 | 703,194 |
---|
Total assets | 12 | 7 |
---|
Accounts payable | 515,245 | 496,702 |
---|
Accrued and other current liabilities | 1 | 425,932 |
---|
Total liabilities | 2 | 922,634 |
---|
Common Stock, par value $0.0001, 250,000,000 shares authorized, and 12,321,848 shares issued and outstanding as of December 31, 2022; and 90,000,000 shares authorized and 8,328,629 shares issued and outstanding as of December 31, 2021, respectively | 833 | 1,232 |
---|
Additional paid-in capital | 46 | 52 |
---|
Accumulated deficit | -35,982,275 | -45,593,188 |
---|
Total stockholders' equity | 10 | 6 |
---|
Total liabilities and stockholders' equity | 12 | 7 |
---|